Back
Range Cancer Therapeutics ETF Quote, Financials, Valuation and Earnings
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
63
CNCR
Range Cancer Therapeutics ETF
Last Price:
15.58
Seasonality Move:
8.86%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!Range Cancer Therapeutics ETF Price Quote
$15.58
-0.01 (2.77%)
(Updated: November 7, 2024 at 5:09 AM ET)
Range Cancer Therapeutics ETF Key Stats
Buy
63
Range Cancer Therapeutics ETF (CNCR)
is a Buy
Day range:
$15.46 - $15.73
52-week range:
$9.52 - $17.96
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
3.1K
Avg. volume:
3.2K
1-year change:
49.4%
Market cap:
$0
Revenue:
$0
EPS:
$0
How Much Does Range Cancer Therapeutics ETF Make?
Data Unavailable
Is Range Cancer Therapeutics ETF Growing As A Company?
Data Unavailable
Range Cancer Therapeutics ETF Stock Price Performance
-
Did Range Cancer Therapeutics ETF Stock Go Up Last Month?
Range Cancer Therapeutics ETF share price went up by 4.28% last month -
Did CNCR's Share Price Rise Over The Last Year?
CNCR share price rose by 49.4% over the past 1 year
What Is Range Cancer Therapeutics ETF 52-Week High & Low?
-
What Is Range Cancer Therapeutics ETF’s 52-Week High Share Price?
Range Cancer Therapeutics ETF has traded as high as $17.96 over the past 52 weeks -
What Is Range Cancer Therapeutics ETF’s 52-Week Low Share Price?
Range Cancer Therapeutics ETF has traded as low as $9.52 over the past 52 weeks
Range Cancer Therapeutics ETF Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Range Cancer Therapeutics ETF?
Data Unavailable
Is Range Cancer Therapeutics ETF Cash Flow Positive?
Data Unavailable
Range Cancer Therapeutics ETF Return On Invested Capital
Data Unavailable
Range Cancer Therapeutics ETF Earnings Date & Stock Price
-
What Is Range Cancer Therapeutics ETF's Stock Price Today?
A single share of CNCR can be purchased today for 15.59 -
What Is Range Cancer Therapeutics ETF’s Stock Symbol?
Range Cancer Therapeutics ETF trades on the nasdaq under the ticker symbol: CNCR -
When Is Range Cancer Therapeutics ETF’s Next Earnings Date?
The next quarterly earnings date for Range Cancer Therapeutics ETF is scheduled on November 8, 2024 -
When Is CNCR's next ex-dividend date?
Range Cancer Therapeutics ETF's next ex-dividend date is December 29, 2021 -
How To Buy Range Cancer Therapeutics ETF Stock?
You can buy Range Cancer Therapeutics ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Range Cancer Therapeutics ETF Competitors
-
Who Are Range Cancer Therapeutics ETF's Competitors?
Below is a list of companies who compete with Range Cancer Therapeutics ETF or are related in some way:
Range Cancer Therapeutics ETF Dividend Yield
-
What Is CNCR Dividend Yield?
Range Cancer Therapeutics ETF’s dividend yield currently is 0% -
What Is Range Cancer Therapeutics ETF’s Payout Ratio?
Range Cancer Therapeutics ETF’s payout ratio is 0% -
When Did Range Cancer Therapeutics ETF Last Pay A Dividend?
The latest dividend pay date is November 8, 2024 -
What Is Range Cancer Therapeutics ETF’s Dividend Per Share?
Range Cancer Therapeutics ETF pays a dividend of $0.00 per share
Range Cancer Therapeutics ETF Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |
Major Shareholders
Data Unavailable